Skip to main content
40 search results for:

Polymyositis 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-03-2022 | Myositis | News | Article

    Mixed results for branched-chain amino acids in polymyositis, dermatomyositis

    Branched-chain amino acid supplementation has no impact on muscle strength or clinical response in people with polymyositis or dermatomyositis but may improve dynamic repetitive muscle function, Japanese study data show.

  2. 22-07-2021 | Polymyositis | Article

    Heart failure risk increased in polymyositis, dermatomyositis

    People with newly-diagnosed polymyositis or dermatomyositis have a significantly higher 10-year risk for heart failure hospitalization than people who do not have these conditions, suggests research conducted in Taiwan.

  3. 01-11-2019 | Infection | News | Article

    Burden of opportunistic infections high for patients with polymyositis, dermatomyositis

    A 13-year cohort study indicates that systemic rheumatic diseases are associated with an increased incidence of opportunistic infections, and suggests that patients with polymyositis or dermatomyositis have the highest rates.

  4. 22-10-2021 | Dermatomyositis | News | Article

    New EULAR/ACR dermatomyositis criteria shed light on disease frequency, mortality

    A population-based cohort study using the 2017 EULAR/American College of Rheumatology criteria for dermatomyositis has identified a higher incidence, prevalence, and associated mortality rate than previously reported.

  5. 22-07-2021 | Dermatomyositis | News | Article
    approvalsWatch

    IVIG receives FDA approval for dermatomyositis

    The US FDA has approved intravenous immunoglobulin for the treatment of dermatomyositis in adults.

  6. 03-06-2021 | EULAR 2021 | Conference coverage | Article

    ProDERM demonstrates benefits of IVIG in patients with dermatomyositis

    Phase 3 trial results suggest that intravenous immunoglobulin may be a promising treatment option for patients with dermatomyositis.

  7. 16-07-2018 | Dermatomyositis | Article

    Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis

    Mamyrova G et al. Rheumatology (Oxford) 2018. doi: 10.1093/rheumatology/key190

  8. 20-11-2018 | Myositis | Article

    Long-term follow-up of autologous hematopoietic stem cell transplantation for refractory juvenile dermatomyositis: A case-series study

    The authors report the treatment and follow-up of three patients with refractory juvenile dermatomyositis who received autologous hematopoietic stem

  9. 20-06-2018 | Dermatomyositis | Article

    Current management of juvenile dermatomyositis in Germany and Austria: An online survey of pediatric rheumatologists and pediatric neurologists

    Background: Juvenile Dermatomyositis (JDM) is a rare pediatric autoimmune disease with broad variations of the individual course.

  10. 11-08-2022 | Guidelines | News | Article
    guidelinesWatch

    Updated European guidance on vaccination issued for pediatric rheumatology patients

    Click through for more details on the EULAR recommendations

  11. 27-05-2022 | Myositis | News | Article

    Pain and opioid use common in myositis

    Of the 423 people (74.6% women) who completed the survey, 43.3% had dermatomyositis, 31.0% had inclusion body myositis, and 25.7% had polymyositis.

  12. 01-11-2016 | Myositis | Review | Article

    Recent advances in dermatomyositis-specific autoantibodies

    Fujimoto M et al. Curr Opin Rheumatol 2016; 28: 636–644. doi: 10.1097/BOR.0000000000000329

  13. 25-06-2018 | Dermatomyositis | Article

    Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria

    The juvenile dermatomyositis working group of the Society for Pediatric Rheumatology aims to define consensus- and practice-based strategies in order

  14. 12-06-2018 | Dermatomyositis | Article

    Introduction of a novel magnetic resonance imaging-based scoring system for assessing disease activity in children with juvenile dermatomyositis

    Thyoka M et al. Rheumatology (Oxford) 2018: key144. doi: 10.1093/rheumatology/key144

  15. 10-11-2021 | ACR 2021 | Conference coverage | Article

    Increased risk for breakthrough COVID-19 infection in vaccinated patients with AIRDs

    Singh reported that the odds of breakthrough infection in the 524,624 fully vaccinated individuals were significantly increased for those with polymyositis/ dermatomyositis rheumatoid arthritis (RA), vasculitis, multiple rheumatic diseases, or gout compared with non-immunosuppressed or compromised individuals, at respective odds ratios of 1.97, 1.33, 1.19, 1.17, and 1.14.

  16. 07-11-2021 | ACR 2021 | Conference coverage | Article

    Belimumab, arimoclomol disappoint in myositis trials

    Participants were aged a median of around 46 years; approximately two-thirds had polymyositis, while a third had dermatomyositis.

  17. 01-11-2021 | COVID-19 | News | Article

    COVID-19: Inactivated vaccine has ‘moderate’ immunogenicity in myopathy patients

    For the current study, Samuel Shinjo and colleagues from Universidade de São Paulo in Brazil evaluated vaccine immunogenicity in 53 patients with systemic autoimmune myopathies, most commonly antisynthetase syndrome (47.2%) or dermatomyositis (45.3%), all of whom had stable or low disease activity.

  18. 13-08-2021 | Rituximab | News | Article

    ‘Substantial risk’ for hypogammaglobulinemia with rituximab in childhood-onset rheumatic diseases

    The study included 85 patients who received rituximab for the treatment of a childhood-onset rheumatic disease; 53 had systemic lupus erythematosus and other related diseases, 14 had vasculitis, 13 had juvenile idiopathic arthritis, four had juvenile dermatomyositis, and one had polymyositis.

  19. 26-05-2021 | Myositis | News | Article
    News in brief

    ​​​​​​​Myositis linked to elevated stroke risk

    When the analysis was restricted to patients with dermatomyositis (four studies), these people had a significant 1.49-fold higher stroke risk than controls.

  20. 09-04-2021 | COVID-19 | News | Article
    News in brief

    Researchers probe link between COVID-19 and autoimmunity

    As reported in a correspondence to The Lancet Rheumatology , there were six cases of systemic rheumatic disease in the COVID-19 group – one each of seronegative inflammatory arthritis, giant cell arteritis, dermatomyositis, antiphospholipid syndrome, seronegative rheumatoid arthritis, and primary Sjögren’s syndrome.

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.